|Articles|April 1, 2014
- BioPharm International-04-01-2014
- Volume 27
- Issue 4
BioPharm International, April 2014 Issue (PDF)
Click the title above to open the BioPharm International April 2014 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 12 years ago
Line of Environmental Measurement Productsalmost 12 years ago
UPLC Separation Intergrates into Mass Spectrometersalmost 12 years ago
FDA and Manufacturers Seek a More Secure Drug Supply Chainalmost 12 years ago
High-Performance Separation-Electrospray Ionization Systemalmost 12 years ago
Biotech IPOs on a Hot Streakalmost 12 years ago
Global Instability Affects the Pharma Market in Brazilalmost 12 years ago
Raw Material Variabilityalmost 12 years ago
Monoclonal Antibodies Key to Unlocking the Biosimilars Marketalmost 12 years ago
Publishing Beyond the Printed PageNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
3
Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)
4
Eli Lilly Announces New $3.5 Billion Manufacturing Facility in Pennsylvania
5
